Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Capmatinib for advanced non-small cell lung cancer	Capmatinib (INC280)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2021	View \| Download
Capivasertib with paclitaxel for previously untreated locally advanced or metastatic triple-negative breast cancer	Capivasertib , Paclitaxel (Taxol; paclitaxel albumin)	Breast cancer	Breast Cancer	2023	View \| Download
Capivasertib with fulvestrant for HR+/HER2- locally advanced or metastatic breast cancer	Capivasertib , Fulvestrant (Faslodex)	Breast cancer	Breast Cancer	2023	View \| Download
Capivasertib with abiraterone acetate for treating metastatic PTEN deficient hormone-sensitive prostate cancer	Abiraterone acetate (Zytiga; Yonsa) , Capivasertib	Prostate cancer	Male Reproductive Cancer	2024	View \| Download
Cannabidiol in a pharmaceutical formulation (Epidiolex; GWP42003-P) for Lennox-Gastaut syndrome in children and adults	Cannabidiol (BRCX-014; Epidiolex; GW42003; GWP42003; GWP-42003; PG-DN-20WS)	Lennox-Gastaut syndrome	Neurology	2017	View \| Download
Cannabidiol (Epidiolex) for Tuberous Sclerosis Complex - add-on therapy	Cannabidiol (BRCX-014; Epidiolex; GW42003; GWP42003; GWP-42003; PG-DN-20WS)	Tuberous sclerosis	Genetic Disorders	2017	View \| Download
Canakinumab in addition to pembrolizumab and platinum-based chemotherapy for locally advanced or metastatic non-small-cell lung cancer (NSCLC)	Canakinumab (Ilaris; ACZ885) , Pembrolizumab (Keytruda; MK-3475)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2021	View \| Download
Canakinumab for Schnitzler syndrome	Canakinumab (Ilaris; ACZ885)	Schnitzler syndrome	Immunology	2021	View \| Download
Canakinumab adjuvant therapy for treating completely resected non-small-cell lung cancer	Canakinumab (Ilaris; ACZ885)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2022	View \| Download
Canakinumab (ILARIS) for Cardiovascular risk reduction – Add on therapy	Canakinumab (Ilaris; ACZ885)	Cardiovascular disease (CVD)	Cardiovascular System	2017	View \| Download